MASI
Get informed when a big investor buys or sells
+ FollowOvervalued by 73.5% based on the discounted cash flow analysis.
| Market cap | $9.34 Billion |
|---|---|
| Enterprise Value | $9.74 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.83 |
| Beta | 1.13 |
| Outstanding Shares | 52,200,000 |
| P/E Ratio | 122.09 |
|---|---|
| PEG | -91.48 |
| Price to Sales | 6.16 |
| Price to Book Ratio | 11.92 |
| Enterprise Value to Revenue | 6.25 |
| Enterprise Value to EBIT | 30.8 |
| Enterprise Value to Net Income | 127 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.66 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0923▼ 219.81% |
|---|---|
| Total Calls | 1,498,735▲ 5410.06% |
| Total Puts | 138,400▲ 122.15% |
Holdings and activity of institutional investors.
| Ownership % | 99.61%▼ 2.90% |
|---|---|
| Total Invested | $9.47B▲ 31.53% |
| Investors Holding | 459▲ 62.00% |
No data
This powerful committee controls taxation, trade, and entitlement spending (like Medicare). Its decisions on corporate tax policy, tariffs impacting supply chains, and Medicare reimbursement rates for medical devices directly influence Masimo's profitability and market access.
This committee allocates discretionary federal spending. Its subcommittees determine specific funding for federal healthcare programs, scientific research (e.g., NIH), and agencies that purchase medical devices, directly impacting Masimo's potential revenue streams from government contracts.
This committee has direct oversight over the Food and Drug Administration (FDA), which is the primary regulatory body for electromedical devices. Its decisions on drug and device approvals, as well as labor laws, directly impact Masimo's operations and market access.
This committee oversees antitrust laws and intellectual property (IP). IP protection (patents, trademarks) is critical for medical device companies like Masimo, making this committee's influence on IP law and antitrust enforcement highly relevant for competition and market position.
This committee oversees the Department of Veterans Affairs (VA). As the VA is a major healthcare provider, its funding and procurement decisions directly impact medical device manufacturers like Masimo, which could supply devices to VA hospitals.